ACTIGRAFT – Product Brief
Recreating the Natural Wound Healing Environment Meet ActiGraft®: ActiGraft® is a Biological Wound Care Device/ Treatment for chronic wounds management. Actigraft is the first wound care product that enables health…
Graft-In co-provided revolutionary ActiGraft to aid Ukraine
04/2022 An innovative wound care system to help the wounded, has arrived in Ukraine – Thanks to the collaboration between RedDress, a Florida-based Medical Company, Graft-In, a Cypriot medical marketing…
Launching in Azerbaijan: MOH approval
03/2022 – Actigraft has received the approval of the Ministry of Health in Azerbaijan. We are launching the activity in hospitals and clinics countrywide.
Graft-In at WUWHS2022 conference UAE exhibition
03/2022: Graft-In took part in the WUW conference for wound in the UAE exhibition. together with the manufacturer Redders and our local distributor Imperial Middle East, the Actigraft treatment was…
Launching in Ukraine: MOH approval
02/2022 – Actigraft has received the approval of the Ministry of Health in Ukraine. SALAVAMED, our official partner there, is launching the activity in hospitals and clinics in order to…
Azerbaijan: Conference at the University Hospital
11.2021 - Graft-in started cooperation on the Ministry of Health in Azerbaijan. The activity began in a conference at the University Hospital in Baku with the introduction of ACTIGRAFT to…
Launchin a joint activity in the UAE
On 15.12.2021, Graft-in and Imperial Middle East with the assistance of consider consultancy, launched the joint activity in the UAE for ACTIGRAFT® treatments in hospitals in Abu Dhabi and Dubai.